Skip to main content
School of Public Health
block W logo University of Washington

Caleb Banta-Green

faculty photo
Affiliate Associate Professor, Health Services

Principal Research Scientist, Alcohol and Drug Abuse Institute
University of Washington

Education

PhD   University of Washington, 2008   (Health Services Research)
MPH   University of Washington, 1997   (Public Health)
MSW   University of Washington, 1996   (Social Work)

Contact Info

email:   calebbg@uw.edu
web site:   http://bit.ly/adaistaff_bantagreen

address:
1107 NE 45th. Suite 120
Seattle, WA 98105

voice:   206-685-3919
fax:   206-543-5473

Drug abuse epidemiology; health services research; youth substance abuse prevention; drug overdose prevention; drug treatment services research


Banta-Green CJ, Williams JR, Sears JM, Floyd AS, Tsui JI, Hoeft TJ. Impact of a jail-based treatment decision-making intervention on post-release initiation of medications for opioid use disorder. Drug Alcohol Depend. 2020 Feb 1;207:107799. doi: 10.1016/j.drugalcdep.2019.107799. Epub 2019 Dec 11.  PMID: 31865058
PubMed
 
DOI
 


Banta-Green CJ, Floyd AS, Vick K, Arthur J, Hoeft TJ, Tsui JI. Opioid Use Disorder Treatment Decision Making And Care Navigation Upon Release From Prison: A Feasibility Study. Subst Abuse Rehabil. 2019 Oct 22;10:57-67. doi: 10.2147/SAR.S192045. eCollection 2019.  PMID: 31695555    PMCID: PMC6815213
PubMed
 
PubMed Central
 
DOI
 


Burgard DA, Williams J, Westerman D, Rushing R, Carpenter R, LaRock A, Sadetsky J, Clarke J, Fryhle H, Pellman M, Banta-Green CJ. Using wastewater-based analysis to monitor the effects of legalized retail sales on cannabis consumption in Washington State, USA. Addiction. 2019 Jun 18. doi: 10.1111/add.14641. [Epub ahead of print]  PMID: 31211480    PMCID: PMC6814135
PubMed
 
PubMed Central
 
DOI
 


Hood JE, Banta-Green CJ, Duchin JS, Breuner J, Dell W, Finegood B, Glick SN, Hamblin M, Holcomb S, Mosse D, Oliphant-Wells T, Shim MM. Engaging an unstably housed population with low-barrier buprenorphine treatment at a syringe services program: Lessons learned from Seattle, Washington. Subst Abus. 2019 Aug 12:1-9. doi: 10.1080/08897077.2019.1635557. [Epub ahead of print]  PMID: 31403907
PubMed
 
DOI
 


Duncan MH, Ratzliff AD, Powers DM, Banta-Green CJ, Saxon AJ. The Next Stage of Buprenorphine Care for Opioid Use Disorder. Ann Intern Med. 2019 Jun 4;170(11):820-821. doi: 10.7326/L19-0144.  PMID: 31158865
PubMed
 
DOI
 


2019
Chair, thesis committee for Connor Henry
Qualitative Analysis of Treatment Barriers for Syringe Exchange

2019
Chair, dissertation committee for Vanessa McMahan
Evaluating Interest and Uptake of Methamphetamine Reduction and Pre-exposure Prophylaxis (PrEP) Interventions among Cismen who Have Sex with Men (MSM) and Injection Drug Users (IDU) who Use Methamphetamine

2017
Chair, thesis committee for Madeline Frost
Factors associated with interest in drug treatment among syringe exchange clients who use opioids

2016
Member, thesis committee for Elly Riser
The demographic characteristics and cardiovascular pathology of methamphetamine overdose decedents in King County, Washington